SCHEMBL30875141

SCHEMBL30875141

CC(C)(C)OC(=O)N1CC(C(F)(F)F)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.51
USP2 O75604 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
RORC P51449 1/20 0.45
HPGD P15428 1/20 0.42
RECQL P46063 1/20 0.41
EPHX1 P07099 1/20 0.41
PDE4B Q07343 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
NAMPT P43490 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
USP30 Q70CQ3 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
LIPE Q05469 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25308687 0.87 NR1H2 (0.48) NR1H2USP2SMN1; SMN2RORCHPGD
SCHEMBL29890877 0.86 HPGD (0.49) NR1H2USP2SMN1; SMN2HPGDRECQL
SCHEMBL28850128 0.86 HPGD (0.49) NR1H2USP2SMN1; SMN2HPGDRECQL
SCHEMBL24113030 0.86 HPGD (0.49) NR1H2USP2SMN1; SMN2HPGDRECQL
SCHEMBL18987169 0.85 NR1H2 (0.47) NR1H2RORCHPGDRECQLLIPE
SCHEMBL21995658 0.84 NR1H2 (0.46) NR1H2USP2SMN1; SMN2RORCHPGD
SCHEMBL8395258 0.84 NR1H2 (0.54) NR1H2USP2SMN1; SMN2RORCHPGD
SCHEMBL17481686 0.84 RORC (0.48) NR1H2USP2SMN1; SMN2RORCHPGD
SCHEMBL16057136 0.84 RORC (0.48) NR1H2USP2SMN1; SMN2RORCHPGD
SCHEMBL31556728 0.83 MEN1 (0.52) USP2SMN1; SMN2HPGDRECQLEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117957212-A IL-17A modulators based on phenylacetamide and uses thereof 戴斯阿尔法公司 2024-04-30 CN disclosed